Day One to Attend the 37th Annual Healthcare Conference Hosted by Piper Sandler

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Nov 18 2025

0mins

Source: Globenewswire

Company Announcement: Day One Biopharmaceuticals will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 4:00 p.m. EST, with a live webcast available for viewing.
Focus on Pediatric Cancer: The company aims to address the lack of therapeutic development in pediatric cancer, inspired by the initial conversations between physicians and families regarding cancer diagnoses and treatment plans.
Collaborative Approach: Day One partners with clinical oncologists, families, and scientists to develop targeted cancer treatments, with a pipeline that includes tovorafenib (OJEMDA™) and DAY301.
Investor Relations: The company utilizes its Investor Relations website and social media platforms to communicate news, announcements, and financial performance to stakeholders.

Get Free Real-Time Notifications for Any Stock

Monitor tickers like undefined with instant alerts to capture every critical market movement.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.